The Kraft Heinz Company has signed an agreement to sell 100% of its equity shares in Heinz India to Zydus Wellness and Cadila Healthcare, in a deal valued at about INR46bn ($625m).

Heinz India consists of Complan, Glucon-D, Nycil and Sampriti brands, in addition to two manufacturing facilities. About 900 employees are associated with these brands and operations.

Kraft Heinz CEO Bernardo Hees said: “The sale of this niche business fits into our overall global growth strategy and our focus on investing in and growing brands within our core categories.

“India continues to be a key market for Kraft Heinz, and in fact, we’re strengthening our commitment to expand and grow our Heinz sauces and Kraft business in India.”

“The sale of this niche business fits into our overall global growth strategy and our focus on investing in and growing brands within our core categories.”

Heinz India generates about $150m in net sales and about $30m in adjusted EBITDA.

J.P. Morgan Securities served as financial advisor to Kraft Heinz. Indian firm Cyril Amarchand Mangaldas and global law firm Gibson, Dunn & Crutcher served as legal advisors.

Kraft Heinz added that the sale of its Indian business will not have a material impact on its annual financial results.

Subject to regulatory approvals and other customary closing conditions, the deal is expected to be completed early next year.

Kraft Heinz’s brands include Kraft, Heinz, ABC, Capri Sun, Classico, Jell-O, Kool-Aid, Lunchables, Maxwell House, Ore-Ida, Oscar Mayer, Philadelphia, Planters, Plasmon, Quero, Smart Ones and Velveeta.

Free Whitepaper How electronic inspection sensors prevented a potentially extremely costly product recall

A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation. This document explains how DJA Pharma prevented a costly recall with a simple, elegant and effective solution.

Enter your details here to receive your free whitepaper.

Machinery whitepaper

Download our whitepaper

Yes I have read and accept the terms and conditions and privacy policys.


You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our Verdict Privacy Policy to see how we protect and manage your submitted data.

You will receive your free whitepaper after you submit the form.

Close